Patient factors associated with SSRI dose for depression treatment in general practice: A primary care cross sectional study

BMC Family Practice

Volumn 15, Issue 1, 2014, Pages

  Johnson, Chris F ^a   Dougall, Nadine J ^b   Williams, Brian ^b   MacGillivray, Stephen A ^c   Buchanan, Alasdair I ^a   Hassett, Richard D ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b UNIVERSITY OF STIRLING   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Antidepressive agents; Benzodiazepines; Chronic disease; Depression; Family practice

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; CLINICAL PRACTICE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER; FEMALE; GENERAL PRACTICE; HUMAN; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; BENZODIAZEPINES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; GENERAL PRACTICE; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; MIDDLE AGED; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; YOUNG ADULT;

EID: 84923868007     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-014-0210-9     Document Type: Article

References (63)

1. Parish PA: The prescribing of psychotropic drugs in general practice. J R Coll Gen Pract 1971, 21(92 Suppl 4):1-77.
2. Middleton N, Gunnell D, Whitley E, Dorling D, Frankel S: Secular trends in antidepressant prescribing in the UK, 1975-1998. J Public Health Med 2001, 23(4):262-267.
3. Knapp M, McDaid D, Mossailos E, Thornicroft G: Mental health policy and practice across Europe: the future direction of mental health care. Maidenhead: McGraw-Hill, Open University Press; 2007.
4. Chen Y, Kelton CM, Jing Y, Guo JJ, Li X, Patel NC: Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Res Soc Admin Pharm 2008, 4(3):244-257.
5. Stephenson CP, Karanges E, McGregor IS: Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry 2013, 47(1):74-87.
6. Spence D: Are antidepressants overprescribed? Yes. BMJ 2013, 346:f191.
7. Reid IC: Are antidepressants overprescribed? No. BMJ 2013, 346: f190.
8. Information Services Division Scotland: Prescribing Statistics Medicines used in Mental Health: Full Reports. [http://www.isdscotland.org/Health-Topics/Prescribing-and-Medicines/Publications/index.asp]
9. Smith-Merry J, Freeman R, Sturdy S: Indicating mental health in Scotland. Knowledge and Policy in education and health sectors; 2010. [http://knowandpol. eu/IMG/pdf/o32.scotlandeducation.pdf]
10. Petty DR, House A, Knapp P, Raynor T, Zermansky A: Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing 2006, 35(5):523-526.
11. Donoghue JM, Tylee A: The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatr 1996, 168(2):164-168.
12. Johnson CF, Macdonald HJ, Atkinson P, Buchanan AI, Downes N, Dougall N: Reviewing long-term antidepressants can reduce drug burden: A prospective observational cohort study. Br J Gen Pract 2012, 62(604):e773-e779.
13. British National Formulary 67: BMA and Royal Pharmaceutical Society. London: Pharmaceutical Press; 2014.
14. Lee KC, Feldman MD, Finley PR: Beyond depression: evaluation of newer indications and off-label uses for SSRIs. Formulary 2002, 37(6):312-319.
15. Munoz-Arroyo R, Sutton M, Morrison J: Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. Br J Gen Pract 2006, 56(527):423-428.
16. Moore M, Yuen H, Dunn N, Mullee MA, Maskell J, Kendrick T: Explaining the rise in antidepressant prescribing: A descriptive study using the general practice research database. BMJ 2009, 339(7727):956.
17. Lockhart P, Guthrie B: Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br J Gen Pract 2011, 61(590):e565-e572.
18. World Health Organisation: Definitions and general considerations. [http://www.whocc.no/ddd/definition-and-general-considera/]
19. Morrison J, Anderson MJ, Sutton M, Munoz-Arroyo R, McDonald S, Maxwell M, Smith M, Wilson P: Factors influencing variation in prescribing of antidepressants by general practices in Scotland. Br J Gen Pract 2009, 59(559):e25-e31.
20. Chapman DP, Perry GS, Strine TW: The vital link between chronic disease and depressive disorders. Prev Chron Dis 2005, 2(1):A14.
21. Egede LE: Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry 2007, 29(5):409-416.
22. Weinberger AH, McKee SA, Picciotto MR, Mazure CM: Examining antidepressant drug response by smoking status: why is it important and how often is it done? J Psychopharmacol 2011, 25 (10):1269-1276.
23. Ashton H: Toxicity and adverse consequences of benzodiazepine use. Psychiatr Ann 1995, 25(3):158-165.
24. Kripke DF: Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 2007, 7:42.
25. Morrison J, Anderson M, Mac Donald S, Maxwell M, Munoz-Arroyo R, Power A, Smith M, Sutton M, Wilson P: Relationship between antidepressant and anxiolytic/hypnotic prescribing: a mixed-methods study. Eur J Gen Pract 2008, 14 (3-4):129-135.
26. McCormack C: More than Medication: A Strategy to Promote Appropriate Antidepressant Prescribing in NHS GG&C; 2007.
27. Health and Social Care Information Centre: Caldicott Guardians. [http://systems.hscic.gov.uk/data/ods/searchtools/caldicott]
28. Information Services Division Scotland: General Practice: practices and their populations. [http://www.isdscotland.org/Health-Topics/General-Practice/Workforce-and-Practice-Populations/Practices-and-Their-Populations/.
29. Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, Matthews K, McAllister-Williams RH, Peveler RC, Scott J, Tylee A: Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 2008, 22(4):343-396.
30. National Collaborating Centre for Mental Health: Clinical Guideline 90. Depression in adults: the treatment and management of depression in adults. 2009. [http://www.nice.org.uk/guidance/cg90]
31. Taylor D, Paton C, Kapur S: The Maudsley Prescribing Guidelines in Pyschiatry. 11th edition. Chichester: Wiley-Blackwell; 2012.
32. Scottish Index of Multiple Deprivation: General Report. 2009 [http://www.scotland.gov.uk/Publications/2009/10/28104046/1]
33. Chisholm J: The Read clinical classification. BMJ 1990, 300(6732):1092.
34. Mitchell AJ, Vaze A, Rao S: Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 2009, 374(9690):609-619.
35. Donoghue J, Lader M: Antidepressants are associated with increased length of hypnotic use in primary care. Eur Neuropsychopharmacol 2008, 18(S4):S326-S327.
36. Adli M, Baethge C, Heinz A, Langlitz N, Bauer M: Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci 2005, 255(6):387-400.
37. Corruble E, Guelfi JD: Does increasing dose improve efficacy in patients with poor antidepressant response: a review. Acta Psychiatr Scand 2000, 101(5):343-348.
38. Austin PC: Estimating multilevel logistic regression models when the number of clusters is low: a comparison of different statistical software procedures. Int J Biostat 2010, 16:6(1): Article 16. doi: 10.2202/1557-4679.1195
39. Burton C, Anderson N, Wilde K, Simpson CR: Factors associated with duration of new antidepressant treatment: analysis of a large primary care database. Br J Gen Pract 2012, 62 (595):e104-e112.
40. National Collaborating Centre for Mental Health: Clinical Guideline 91. Depression in adults with a chronic physical health problem: Treatment and management. 2009. [http://www.nice.org.uk/guidance/cg91]
41. Scottish Intercollegiate Guidelines Network: Non-pharmaceutical management of depression in adults. SIGN 114; 2010. [http://www.sign.ac.uk/guidelines/fulltext/114/index.html]
42. Kendrick T, Dowrick C, McBride A, Howe A, Clarke P, Maisey S, Moore M, Smith PW: Management of depression in UK general practice in relation to scores on depression severity questionnaires: Analysis of medical record data. BMJ 2009, 338(7697):b750.
43. Hull SA, Cornwell J, Harvey C, Eldridge S, Bare PO: Prescribing rates for psychotropic medication amongst east London general practices: low rates where Asian populations are greatest. Fam Pract 2001, 18(2):167-173.
44. Walters P, Ashworth M, Tylee A: Ethnic density, physical illness, social deprivation and antidepressant prescribing in primary care: ecological study. Br J Psychiatr 2008, 193(3):235-239.
45. Sinclair JE, Aucott LS, Lawton K, Reid IC, Cameron IC: The monitoring of long term prescriptions if antidepressants: observational study in a primary care setting. Fam Pract 2014, 31(4):419-426.
46. Schofield P, Crosland A, Waheed W, Aseem S, Gask L, Wallace A, Dickens A, Tylee A: Patients' views of antidepressants: from first experiences to becoming expert. Br J Gen Pract 2011, 61(585):142-148.
47. Malpass A, Kessler D, Sharp D, Shaw A: 'I didn't want her to panic': unvoiced patient agendas in primary care consultations when consulting about antidepressants. Br J Gen Pract 2011, 61(583):e63-e71.
48. Hyde J, Evans J, Sharp D, Croudace T, Harrison G, Lewis G, Araya R: Deciding who gets treatment for depression and anxiety: A study of consecutive GP attenders. Br J Gen Pract 2005, 55(520):846-853.
49. Macdonald S, Morrison J, Maxwell M, Munoz-Arroyo R, Power A, Smith M, Sutton M, Wilson P: 'A coal face option': GPs' perspectives on the rise in antidepressant prescribing. Br J Gen Pract 2009, 59(566):e299-e307.
50. McManus P, Mant A, Mitchell P, Britt H, Dudley J: Use of antidepressants by general practitioners and psychiatrists in Australia. Aust N Z J Psychol 2003, 37(2):184-189.
51. Truter I, Kotze TJ: An investigation into the prescribing patterns of selective serotonin re-uptake inhibitors in South Africa. J Clin Pharm Ther 1996, 21(4):237-242.
52. Andrews G: Should depression be managed as a chronic disease? BMJ 2001, 322(7283):419-421.
53. Rix S, Paykel ES, Lelliott P, Tylee A, Freeling P, Gask L, Hart D: Impact of a national campaign on GP education: an evaluation of the Defeat Depression Campaign. Br J Gen Pract 1999, 49(439):99-102.
54. Burke WJ, Gergel I, Bose A: Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002, 63(4):331-336.
55. Hu XH, Bull SA, Hunkeler EM, Ming E, Lee JY, Fireman B, Markson LE: Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 2004, 65 (7):959-965.
56. Byrne SE, Rothschild AJ: Loss of antidepressant efficacy during maintenance therapy: Possible mechanisms and treatments. J Clin Psychiatry 1998, 59(6):279-288.
57. Zimmerman M, Thongy T: How often do SSRIs and other new-generation antidepressants lose their effect during continuation treatment? Evidence suggesting the rate of true tachyphylaxis during continuation treatment is low. J Clin Psychiatry 2007, 68(8):1271-1276.
58. Moylan S, Maes M, Wray NR, Berk M: The neuroprogressive nature of major depressive disorder: Pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2013, 18(5):595-606.
59. Pilgrim D, Bentall R: The medicalisation of misery: A critical realist analysis of the concept of depression. J Mental Health 1999, 8(3):261-274.
60. Cameron IM, Lawton K, Reid IC: Appropriateness of antidepressant prescribing: an observational study in a Scottish primary-care setting. Br J Gen Pract 2009, 59(566):644-649.
61. Smith DJ, Griffiths E, Kelly M, Hood K, Craddock N, Simpson SA: Unrecognised bipolar disorder in primary care patients with depression. Br J Psychiatr 2011, 199(1):49-56.
62. Patel B, Afghan S: Effects of an educational outreach campaign (IMPACT) on depression management delivered to general practitioners in one primary care trust. Mental Health Family Med 2010, 6(3):155-162.
63. Scottish Clinical Information Management in Practice January 2009. [http://www.scimp.scot.nhs.uk/better-information/clinical-coding/readcodingsummarising/]